| Product Code: ETC7548250 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Monogenetic Disease Therapy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Monogenetic Disease Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 India Monogenetic Disease Therapy Market - Industry Life Cycle |
3.4 India Monogenetic Disease Therapy Market - Porter's Five Forces |
3.5 India Monogenetic Disease Therapy Market Revenues & Volume Share, By Inheritance Pattern, 2021 & 2031F |
3.6 India Monogenetic Disease Therapy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 India Monogenetic Disease Therapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 India Monogenetic Disease Therapy Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 India Monogenetic Disease Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of monogenetic diseases in India |
4.2.2 Rising awareness about genetic testing and personalized medicine |
4.2.3 Growing investments in research and development for genetic therapies |
4.3 Market Restraints |
4.3.1 High cost associated with genetic therapies |
4.3.2 Limited availability of advanced healthcare infrastructure in certain regions |
5 India Monogenetic Disease Therapy Market Trends |
6 India Monogenetic Disease Therapy Market, By Types |
6.1 India Monogenetic Disease Therapy Market, By Inheritance Pattern |
6.1.1 Overview and Analysis |
6.1.2 India Monogenetic Disease Therapy Market Revenues & Volume, By Inheritance Pattern, 2021- 2031F |
6.1.3 India Monogenetic Disease Therapy Market Revenues & Volume, By Autosomal, 2021- 2031F |
6.1.4 India Monogenetic Disease Therapy Market Revenues & Volume, By Chromosomal, 2021- 2031F |
6.2 India Monogenetic Disease Therapy Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 India Monogenetic Disease Therapy Market Revenues & Volume, By Pharmacological, 2021- 2031F |
6.2.3 India Monogenetic Disease Therapy Market Revenues & Volume, By Surgical, 2021- 2031F |
6.2.4 India Monogenetic Disease Therapy Market Revenues & Volume, By Blood Transfusion, 2021- 2031F |
6.2.5 India Monogenetic Disease Therapy Market Revenues & Volume, By EBRT, 2021- 2031F |
6.2.6 India Monogenetic Disease Therapy Market Revenues & Volume, By Gene Therapies, 2021- 2031F |
6.2.7 India Monogenetic Disease Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Monogenetic Disease Therapy Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 India Monogenetic Disease Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3.3 India Monogenetic Disease Therapy Market Revenues & Volume, By SCID, 2021- 2031F |
6.3.4 India Monogenetic Disease Therapy Market Revenues & Volume, By Sickle Cell Anemia, 2021- 2031F |
6.3.5 India Monogenetic Disease Therapy Market Revenues & Volume, By Phenylketonuria, 2021- 2031F |
6.3.6 India Monogenetic Disease Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Monogenetic Disease Therapy Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 India Monogenetic Disease Therapy Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.3 India Monogenetic Disease Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 India Monogenetic Disease Therapy Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.5 India Monogenetic Disease Therapy Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.4.6 India Monogenetic Disease Therapy Market Revenues & Volume, By Others, 2021- 2031F |
7 India Monogenetic Disease Therapy Market Import-Export Trade Statistics |
7.1 India Monogenetic Disease Therapy Market Export to Major Countries |
7.2 India Monogenetic Disease Therapy Market Imports from Major Countries |
8 India Monogenetic Disease Therapy Market Key Performance Indicators |
8.1 Number of patients diagnosed with monogenetic diseases |
8.2 Number of genetic testing facilities across India |
8.3 Percentage of healthcare professionals trained in genetic therapies |
8.4 Funding and grants allocated to genetic research and development in India |
9 India Monogenetic Disease Therapy Market - Opportunity Assessment |
9.1 India Monogenetic Disease Therapy Market Opportunity Assessment, By Inheritance Pattern, 2021 & 2031F |
9.2 India Monogenetic Disease Therapy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 India Monogenetic Disease Therapy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 India Monogenetic Disease Therapy Market Opportunity Assessment, By End users, 2021 & 2031F |
10 India Monogenetic Disease Therapy Market - Competitive Landscape |
10.1 India Monogenetic Disease Therapy Market Revenue Share, By Companies, 2024 |
10.2 India Monogenetic Disease Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here